03. January 2025

Lexology Index ranks Dr Matthias Ulshöfer among the world’s 15 leading lawyers in the field of ‘Government’

In the newly published Lexology Index by Lexology (formerly Who’s Who Legal), Dr Matthias Ulshöfer is listed as one of the world’s leading lawyers in the field of ‘Government’ – as a ‘Global Elite Thought Leader’, together with 15 other highly esteemed colleagues from around the world.

Client Choice recognises law firms and individuals worldwide who stand out for their exceptional client focus and quality of service. Only corporate counsel can nominate for this award. The survey is based on extensive interviews with clients and general counsel.

Dr. Matthias Ulshöfer

+49 (0)711 60187-290
ulshoefer@oppenlaender.de

More news

All news

27. November 2025

OPPENLÄNDER appoints two new partners

The OPPENLÄNDER partnership is growing. On January 1, 2026, Dr. Henrike Schulte will become a partner and Dr. Joachim Ott a salary partner at OPPENLÄNDER Rechtsanwälte. Both were previously associate partners at the firm.

Read more
21. November 2025

OPPENLÄNDER wins record damages for idealo

idealo has achieved a significant victory against Google in the Berlin Regional Court. The court confirmed that Google abused its market power far beyond the date of the Commission's decision in order to favor its own price comparison service and ordered the US corporation to pay damages of over €465 million, including interest.

Read more
31. October 2025

OPPENLÄNDER again receives JUVE TOP 50 Commercial Law Firm (Wirtschaftskanzlei) Award

"To the point: The strengths of this Stuttgart-based firm are not only in competition law and litigation – Oppenländer also enjoys an excellent reputation for advising in regulated industries." (JUVE quote)

Read more
13. October 2025

No compensation for isolation without possible vaccination – OPPENLÄNDER Rechtsanwälte wins for the state of Baden-Württemberg

On October 9, 2025, the Federal Administrative Court ruled that an employed person who was in quarantine in October 2021 due to infection with the coronavirus and thus suffered a loss of earnings cannot claim compensation from the state under the Infection Protection Act if they did not take advantage of the vaccination publicly recommended at the time despite having sufficient opportunity to do so. Translated with DeepL.com (free version)

Read more